CIS is a consulting firm that focuses on compliance, risk, revenue management and outsource solutions for the healthcare and life science industries... Read more
CIS is a consulting firm that focuses on compliance, risk, revenue management and outsource solutions for the healthcare and life science industries... Read more
News
Jul 10, 2017
CIS by Deloitte Blog
CIS by Deloitte Blog CMS Publishes Implementation Date for Generic Inflation Penalty System Changes in DDR
May 23, 2017
CIS by Deloitte Blog
CIS by Deloitte Blog 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties; Further Delay of Effective Date
May 17, 2017
CIS by Deloitte Blog
CIS by Deloitte Blog Managing Fair Market Value Challenges in a Dynamic Life Sciences Regulatory Environment
May 11, 2017
CIS by Deloitte Blog
CIS by Deloitte Blog Understanding the Implications of Manufacturer Release 104
Apr 27, 2017
CIS by Deloitte Blog
CIS by Deloitte Blog States beginning actions to limit Medicaid drug price increases
Mar 21, 2017
CIS by Deloitte Blog
CIS by Deloitte Blog 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties; Delay of Effective Date
Mar 17, 2017
CIS by Deloitte Blog
CIS by Deloitte Blog 2016 State Utilization Data for Branded Prescription Drug Fee
Mar 13, 2017
CIS by Deloitte Blog
CIS by Deloitte Blog CMS publishes operational guidance on Generic Inflation Penalty
Jan 20, 2017
CIS by Deloitte Blog
CIS by Deloitte Blog What manufacturers need to know about the new Final Rule on the 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties
Nov 29, 2016
CIS by Deloitte Blog
CIS by Deloitte Blog What manufacturers need to know about the new 340B Program Pharmaceutical Pricing Agreement Addendum
CIS by Deloitte Competitors
1
2
3
4
5
6
7
8
9
10